Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R1SV
|
||||
Former ID |
DCL000400
|
||||
Drug Name |
GSK1014802
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bipolar disorder [ICD9: 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300; ICD10:F31, F40-F42] | Phase 2 | [548689] | ||
Company |
GSK
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H12Cl2N2O3
|
||||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)C=CC2=C(NC3=CC(=CC(=C32)Cl)Cl)C(=O)O
|
||||
InChI |
1S/C18H12Cl2N2O3/c19-10-8-13(20)16-12(17(18(24)25)22-14(16)9-10)6-7-15(23)21-11-4-2-1-3-5-11/h1-9,22H,(H,21,23)(H,24,25)/b7-6+
|
||||
InChIKey |
WZBNEZWCNKUOSM-VOTSOKGWSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Blocker | [550963] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.